Moody's Ratings Peer Group
| Aktie | Rating |
|---|---|
| Amgen Inc. | Baa1 |
| Bayer | Baa2 |
| Biogen Inc | Baa2 |
| Johnson & Johnson | Aaa |
| Pfizer Inc. | A1 |
| Pfizer Inc. | A2 |
| Sanofi S.A. | Aa3 |
| Aktie | Rating |
|---|---|
| Amgen Inc. | Baa1 |
| Bayer | Baa2 |
| Biogen Inc | Baa2 |
| Johnson & Johnson | Aaa |
| Pfizer Inc. | A1 |
| Pfizer Inc. | A2 |
| Sanofi S.A. | Aa3 |
| Aktie | Rating |
|---|---|
| Pfizer Inc. | A1 |
| General Electric Co. | A1 |
| Celgene Corp. | A3 |
| Gilead Sciences Inc. | A3 |
| Merck KGaA | A3 |
| Sanofi S.A. | Aa3 |
| Johnson & Johnson | Aaa |
| Amgen Inc. | Baa1 |
| Regeneron Pharmaceuticals Inc. | Baa1 |
| Biogen Inc | Baa2 |